A structure-guided antibody detects SOD1 oligomers in diverse ALS genotypes.
Sangwan, S.; Rieder, H.; Moore, D.; Khanlou, N.; Novitch, B.; Geisberg, M.; Eisenberg, D.
Show abstract
Antibodies offer versatility as diagnostic and therapeutic tools to target specific protein epitopes. However, the transient nature of intermediate protein conformations, such as that of amyloid oligomers, poses a challenge for antibody development. We use a structure-guided approach to generate a monoclonal antibody against oligomers of Superoxide Dismutase 1 (SOD1). Mutations in SOD1 are linked to a subset of familial Amyotrophic Lateral Sclerosis (fALS), a fatal neurodegenerative disease. Based on the corkscrew-like features of non-native SOD1 oligomers previously determined, we generate an antibody specific to SOD1 oligomers. We show that the antibody, CSAb detects SOD1 oligomers, not fibrils or native SOD1, and alleviates the cytotoxic effects of SOD1 oligomers in a cell culture model of primary motor neurons. Immunohistochemical analyses of human ALS subjects show CSAb reactivity in both neuronal and non-neuronal cells. Finally, we provide evidence that CSAb reactive SOD1 oligomers are present in non-SOD1 linked fALS and sporadic ALS subjects. Together, our study provides a new probe against SOD1 oligomers and suggests that cytotoxic SOD1 oligomers are prevalent in diverse ALS genotypes.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, while the Alzheimer's R47H mutant does the opposite 94%
- Distinct alpha-synuclein strains derived from Parkinson's disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model 93%
- Intra-mitochondrial proteostasis is directly coupled to alpha-synuclein and Amyloid β 1-42 pathology 93%
Similar papers in this journal
- Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model 95%
- RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases 94%
- Divergent and Convergent TMEM106B Pathology in Murine Models of Neurodegeneration and Human Disease 93%
Similar papers in this journal
- Fast purification of recombinant monomeric amyloid-β from E. coli and amyloid-β-mCherry aggregates from mammalian cells 94%
- Disease associated mutations in tau encode for changes in aggregate structure conformation 94%
- Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice 92%
Similar papers in this journal
- Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntingtons disease 94%
- Precision Proteoform Design for 4R Tau Isoform Selective Templated Aggregation 93%
- The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.